Neuronetics (STIM:NASDAQ) Investor Relations Material

Overview

Malvern, Pennsylvania-based Neuronetics, Inc. is a commercial stage medical technology company that caters to patients with neurohealth disorders across the globe. The firm specializes in designing, developing, and marketing advanced products, and its latest offering - the NeuroStar Advanced Therapy System - is a non-invasive and non-systemic office-based treatment that is designed to aid adult patients suffering from major depressive disorder. This innovative system employs transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents in targeted areas of the brain associated with mood. Neuronetics' products are sold to psychiatrists through its sales and customer support team. The firm was incorporated in 2001 and continues to lead the way in neurohealth technology.

Frequently Asked Questions

What is Neuronetics's ticker?

Neuronetics's ticker is STIM

What exchange is Neuronetics traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Neuronetics's headquarters?

They are based in Malvern, Pennsylvania

How many employees does Neuronetics have?

There are 51-200 employees working at Neuronetics

What is Neuronetics's website?

It is neurostar.com

What type of sector is Neuronetics?

Neuronetics is in the Healthcare sector

What type of industry is Neuronetics?

Neuronetics is in the Biotechnology industry

Who are Neuronetics's peers and competitors?

The following five companies are Neuronetics's industry peers:

- Immuron Limited

- Genprex, Inc.

- ChromaDex

- Onconova Therapeutics

- Atara Biotherapeutics